Zobrazeno 1 - 10 of 24 pro vyhledávání: '"MaryAnn Go"'
1
Akademický článek
Preclinical optimization of Ly6E-targeted ADCs for increased durability and efficacy of anti-tumor response
Autor: Josefa Dela Cruz Chuh, MaryAnn Go, Yvonne Chen, Jun Guo, Hanine Rafidi, Danielle Mandikian, Yonglian Sun, Zhonghua Lin, Kellen Schneider, Pamela Zhang, Rajesh Vij, Danielle Sharpnack, Pamela Chan, Cecile de la Cruz, Jack Sadowsky, Dhaya Seshasayee, James T. Koerber, Thomas H. Pillow, Gail D. Phillips, Rebecca K Rowntree, C. Andrew Boswell, Katherine R. Kozak, Andrew G. Polson, Paul Polakis, Shang-Fan Yu, Peter S. Dragovich, Nicholas J. Agard
Publikováno v: mAbs, Vol 13, Iss 1 (2021)
Early success with brentuximab vedotin in treating classical Hodgkin lymphoma spurred an influx of at least 20 monomethyl auristatin E (MMAE) antibody-drug conjugates (ADCs) into clinical trials. While three MMAE-ADCs have been approved, most of thes
Externí odkaz: https://doaj.org/article/25ec46df098b446591f757fd46270d3e
Zobrazit plný text záznamu
2
Data from FcRL5 as a Target of Antibody–Drug Conjugates for the Treatment of Multiple Myeloma
Autor: Andrew G. Polson, Allen Ebens, Andrew S. Jack, Andy Rawstron, Ruth de Tute, Jacqueline McBride, Shang-Fan Yu, Suzie J. Scales, Changchun Du, Dionysos Slaga, MaryAnn Go, Bing Zheng, Kristi Elkins
Fc receptor-like 5 (FcRL5/FcRH5/IRTA2/CD307) is a surface protein expressed selectively on B cells and plasma cells. We found that FcRL5 was expressed at elevated levels on the surface of plasma cells from the bone marrow of patients diagnosed with m
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2e2306e48d8ed16ba570e2dd269d88e3
https://doi.org/10.1158/1535-7163.c.6535360
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje